The Tissue Procurement Core Facility was established in 1999 to collect, prepare, and distribute high quality human tissue samples meeting the special needs of the Cancer Center researchers. An approved application and a copy of the researcher's IRB approval are required to receive tissues from the Core Facility. The Core works synergistically with the Cooperative Human Tissue Network (CHTN), and provides unique services exclusively to Cancer Center members as well as priority access to tissues over other intramural and extramural investigators. A wide variety of tissues are available from UHC and other local area hospitals. Normal, benign, and malignant tissues are obtained from surgical resections and autopsies. Matched normal adjacent tissue and tissues from different organ sites from the same donor are also available to researchers. Special emphasis is placed on the acquisition of metastatic tissues to serve Cancer Center initiatives. Tissue samples are prepared according to individual protocols and can be fresh, snap-frozen, or fixed. Sterile tissues can be obtained for the establishment of cell lines or development of xenograft models. Tissues can also be embedded, cut and mounted on slides, and stained. Quality control (QC) reviews are conducted on tissue samples by experienced surgical pathologists to verify diagnosis. Basic demographic and histopathologic data are provided with the tissue samples. A minimal, standardized processing fee is charged to investigators for the time and effort involved in collecting, processing, storing, and distributing the research samples. Chart reviews are conducted by medical residents as a special service to obtain additional clinical information when required. Patient confidentiality is strictly maintained through the use of sample code numbers. The identity of the tissue donor is maintained by the Core Facility in a secure area in the event that follow-up data or samples are requested. Long-term, monitored storage of disease-specific tissues is also available to Cancer Center members. Surveys are conducted to ensure that the core addresses the changing needs of Cancer Center researchers, and additional services such as nucleic acid isolation and development of tissue microarrays may be offered at a future date.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA043703-14
Application #
6658316
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-09-13
Project End
2003-07-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Qiu, Zhaojun; Oleinick, Nancy L; Zhang, Junran (2018) ATR/CHK1 inhibitors and cancer therapy. Radiother Oncol 126:450-464
Elitt, Matthew S; Shick, H Elizabeth; Madhavan, Mayur et al. (2018) Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease. Stem Cell Reports 11:711-726
He, Tian; McColl, Karen; Sakre, Nneha et al. (2018) Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma. Mol Oncol 12:2124-2135
Roche, Kathryn L; Nukui, Masatoshi; Krishna, Benjamin A et al. (2018) Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase. J Virol 92:
Bedell, Hillary W; Hermann, John K; Ravikumar, Madhumitha et al. (2018) Targeting CD14 on blood derived cells improves intracortical microelectrode performance. Biomaterials 163:163-173
Nagaraj, A B; Wang, Q Q; Joseph, P et al. (2018) Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment. Oncogene 37:403-414
Somasegar, Sahana; Li, Li; Thompson, Cheryl L (2018) No association of reproductive risk factors with breast cancer tumor grade. Eur J Cancer Prev 27:140-143
Gu, Xiaorong; Ebrahem, Quteba; Mahfouz, Reda Z et al. (2018) Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates. J Clin Invest 128:4260-4279
Benson, Bryan L; Li, Lucy; Myers, Jay T et al. (2018) Biomimetic post-capillary venule expansions for leukocyte adhesion studies. Sci Rep 8:9328
Bosca, Federica; Bielecki, Peter A; Exner, Agata A et al. (2018) Porphyrin-Loaded Pluronic Nanobubbles: A New US-Activated Agent for Future Theranostic Applications. Bioconjug Chem 29:234-240

Showing the most recent 10 out of 1227 publications